(Q51580700)

7 April 2018

title

Bile acid kinetics and biliary lipid composition in cystic fibrosis. (English)

1 reference

7 April 2018

0 references

Strandvik B

1

1 reference

7 April 2018

Einarsson K

series ordinal

2

1 reference

7 April 2018

Lindblad A

series ordinal

3

1 reference

7 April 2018

Angelin B

series ordinal

4

1 reference

7 April 2018

publication date

1 July 1996

1 reference

7 April 2018

published in

Journal of Hepatology

1 reference

7 April 2018

volume

25

1 reference

7 April 2018

issue

1

1 reference

7 April 2018

page(s)

43-48

1 reference

7 April 2018

Hepatobiliary disease in cystic fibrosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Malabsorption of Bile Acids in Children with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Aspects of bile acid metabolism in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Reduction of bile acid loss in cystic fibrosis by dietary means

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Intestinal bile acid malabsorption in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

In Vivo Bile Acid Uptake from Terminal Ileum in Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Bile acid secretion in cystic fibrosis: evidence for a defect unrelated to fat malabsorption

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Serum bile acid composition in patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Fasting serum bile acid levels in relation to liver histopathology in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Urinary bile acid excretion in correlation to liver histopathology in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Excretion of bile acids in healthy children and children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Biliary lipid metabolism in chronic pancreatitis: influence of steatorrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

The effects of age on alkaline phosphatase and other serologic liver function tests in normal subjects and patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Influence of age on secretion of cholesterol and synthesis of bile acids by the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

The turnover of cholic acid in man: bile acids and steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Biliary lipid composition during treatment with different hypolipidaemic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Abnormal biliary lipid composition in cystic fibrosis. Effect of pancreatic enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Gallstones in cystic fibrosis: a critical reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Genotype analysis for delta F508, G551D and R553X mutations in children and young adults with cystic fibrosis with and without chronic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Analysis of risk factors for the development of liver disease associated with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Morphological findings in the liver of children with cystic fibrosis: a light and electron microscopical study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Bile-duct destruction and collagen deposition: a prominent ultrastructural feature of the liver in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Reduced microbial transformation of bile acids in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Role of free radicals in the pathogenesis of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Defective inhibition by dexamethasone of leukotriene B4 and C4 production by leukocytes in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

Liver function and morphology during long-term fatty acid supplementation in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980326-6

7 January 2021

10.1016/S0168-8278(96)80326-6

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018